# 3.3.1 Serious Cases

**Page range:** 42â€“43

```text
3.3.1
Serious Cases
A total of 740 serious cases reporting 854 AEs were retrieved from the safety database.
Of these 854 AEs, 794 AEs (AEs of interest) were serious while 60 AEs were non-
serious (NSAEs).
Out of the 60 NSAEs, four AEs were reported with Grade 2 severity while the severity
grading for the remaining 56 AEs was not reported. These NSAEs were not assessed
further.
Total cases
(N=806
Serious Cases
(N=740)
Grade 5 Cases
(N=82)
No of Events
(n=86)
Grade 4 Cases
(N=43)
No of Events
(n=47)
Grade 3 Cases
(N=276)
No of Events
(n=311)
Grade 1/2 Cases
(N=73)
No of Events
(n=78)
Cases lacking
Information on
Severity Grading
(N=249)
No of events
(n=272)
Non-serious Cases
(N=66)

43
Drug Safety Report No: 1132062
This section focuses on the analysis of the SAEs reported from 740 cases. An overview
of these SAEs with respect to severity is presented in Table 12.
Table 12 Distribution of SAEs by Severity Grade, for Cases treated with
Pralsetinib from Safety Database (n=794)
Severity Grade
Frequency of AEs (%)
Grade 5
86 (10.8)
Grade 4
47 (5.9)
Grade 3
311 (39.2)
Grade 2
66 (8.3)
Grade 1
12 (1.5)
Not reported
272 (34.3)
```